A Long Term Study of Clozapine in Patients With Treatment-resistant Schizophrenia

• Status: Completed
• Trial end date: 2009-12-01
• Target enrollment: 0
• Participant gender: All

Summary

Clozapine is an antipsychotic. This open study will evaluate the safety and efficacy of long term treatment of clozapine in patients with treatment-resistant schizophrenia.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Novartis
• Treatments: Clozapine

Criteria

Inclusion Criteria:

• Attended the previous Phase IIb (core) study

• Improved during the core study

• No safety issues during the core study

Exclusion Criteria:

• Discontinued the core study

• Pregnant or nursing (lactating) women

Other protocol-defined exclusion criteria may apply.